Pancreatic Cancer Clinical Trials

Showing 521-540 of 565 trials

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

NCT00433602

RATIONALE: Chemotherapy may cause blood clots to form in the thigh, leg, and lung. This study may help doctors understand how often blood clots occur in patients undergoing chemotherapy. PURPOSE: This clinical trial is studying how often blood clots occur in patients undergoing chemotherapy for solid tumors, including colorectal cancer, stomach cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, or metastatic breast cancer

Breast CancerColorectal CancerGastric Cancer+5 more

European Organisation for Research and Treatment of Cancer - EORTC64 participantsStarted Nov 2006

Amsterdam, Netherlands

COMPLETEDPHASE2

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

NCT00397787

This phase II trial is studying how well sunitinib works in treating patients with metastatic pancreatic cancer that progressed after first-line therapy with gemcitabine. Sunitinib may stop the growth of pancreatic cancer by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth.

Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+1 more

National Cancer Institute (NCI)64 participantsStarted Nov 2006

Chicago, Illinois, United States • New York, New York, United States

TERMINATEDPHASE2

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

NCT00012246

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to compare the effectiveness of two different vaccines in treating patients who have cancer of the gastrointestinal tract.

Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+4 more

The University of Texas Medical Branch, Galveston7 participantsStarted Jul 2002

Galveston, Texas, United States

Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors

Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine

Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract

Related Searches

Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence

Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer

Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer

Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer

Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery

Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma

Efficacy and Safety Study of LE-DT to Treat Locally Advanced or Metastatic Pancreatic Cancer

Regional Versus Systemic Chemotherapy in the Treatment of Unresectable Pancreatic Cancer

Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer

Interleukin-12 in Treating Patients With Cancer in the Abdomen

Isolation and Characterization of Cancer Stem Cells Using iFP Technique

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca

Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer

Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer

Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer